Skip to main content
Clinical Trials/NCT02574923
NCT02574923
Completed
Phase 2

Outcomes of Autologous Bone Marrow Mononuclear Cells for Cerebral Palsy: A Self-Controlled Clinical Trial

Vinmec Healthcare System1 site in 1 country30 target enrollmentNovember 5, 2015
ConditionsCerebral Palsy

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Cerebral Palsy
Sponsor
Vinmec Healthcare System
Enrollment
30
Locations
1
Primary Endpoint
Change in Total Score of Gross Motor Function Measure (GMFM)-88
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

The aim of this study is to assess the safety and effectiveness of autologous bone marrow mononuclear stem cells in patients with cerebral palsy.

Detailed Description

The aim of this study is to assess the safety and effectiveness of autologous bone marrow mononuclear stem cells in 30 patients with cerebral palsy at Vinmec International Hospital, Hanoi, Vietnam.

Registry
clinicaltrials.gov
Start Date
November 5, 2015
End Date
April 30, 2018
Last Updated
7 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Vinmec Healthcare System
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Cerebral palsy of any types caused by oxygen deprivation.

Exclusion Criteria

  • Hydrocephalus with ventricular drain
  • Coagulation disorders
  • Allergy to anesthetic agents
  • Severe health conditions such as cancer, failure of heart, lung, liver or kidney
  • Active infections

Outcomes

Primary Outcomes

Change in Total Score of Gross Motor Function Measure (GMFM)-88

Time Frame: 3 months and 6 months after transplantation

GMFM-88

Change in Gross Motor Function Measure (GMFM)-66 Percentile

Time Frame: 3 months and 6 months after transplantation

GMFM-66 percentile

Secondary Outcomes

  • Change in Quality of Life(3 months and 6 months after transplantation)
  • Change in Denver Developmental Score(3 months and 6 months after transplantation)
  • Number of adverse events(Through study completion, an average of 6 months)
  • Change in Muscle tone(3 months and 6 months after transplantation)

Study Sites (1)

Loading locations...

Similar Trials